Longevity research has long fixated on mitochondria as the central organelle governing aging, but a compelling new body of work repositions that narrative — suggesting that peroxisomes, largely overlooked in geroscience, may be equal partners in determining how quickly organisms age. The implication: targeting a single organelle system may be insufficient if its counterpart is left to decline.

Using the nematode C. elegans, investigators showed that inhibiting PRX-11, a protein that drives peroxisome fission and sets the stage for age-dependent peroxisome degradation via a process called pexophagy, extended lifespan while simultaneously preserving mitochondrial architecture. Animals deficient in PRX-11 function retained tubular, structurally youthful mitochondria into older ages — a morphological signature consistently associated with robust metabolic output. This mitochondrial preservation was mechanistically dependent on three distinct factors: FZO-1 (the worm homolog of mammalian Mitofusin), the calcium/calmodulin kinase UNC-43, and the transcription factor DAF-16/FOXO. Crucially, disrupting any one of these factors completely abolished the lifespan benefit of pexophagy inhibition, establishing that the longevity gain is contingent on co-maintenance of mitochondrial health. Bidirectionality was also demonstrated: experimentally destabilizing mitochondria accelerated pexophagy, suggesting the two organelles engage in reciprocal signaling rather than a simple linear pathway.

This finding is potentially paradigm-shifting in the organelle biology of aging. The peroxisome-mitochondria axis has biochemical logic — both organelles cooperate in fatty acid oxidation and reactive oxygen species metabolism — yet the aging field has rarely treated them as an integrated system. The DAF-16/FOXO link is particularly noteworthy, connecting this crosstalk to the well-validated insulin/IGF-1 longevity pathway. A key limitation is the C. elegans model: the invertebrate aging context may not fully translate to mammals, where peroxisome biology differs in tissue-specific complexity. Nonetheless, mammalian PEX11 homologs exist, and the conserved FOXO connection opens a tractable translational hypothesis worth pursuing in higher organisms.